Comparative effects of intranasal neuropeptide Y and HS014 in preventing anxiety and depressive-like behavior elicited by single prolonged stress

Behavioural Brain Research

Volumn 295, Issue , 2015, Pages 9-16

  Sabban, Esther L ^a   Serova, Lidia I ^a   Alaluf, Lishay G ^a   Laukova, Marcela ^a,b   Peddu, Chandana ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

Author keywords

Anxiety; Depression; HS014; Melanocortin four receptor; NPY; Single prolonged stress

Indexed keywords

BETA INTERMEDIN[11-22][11 (N ACETYLCYSTEINE) 14 [3 (2 NAPHTHYL) DEXTRO ALANINE] 18 CYSTEINE 22 ASPARTIC ACID AMIDE] 11,18 CYCLIC DISULFIDE; CORTICOSTERONE; CORTICOTROPIN; GLUCOCORTICOID RECEPTOR; NEUROPEPTIDE Y; TYROSINE 3 MONOOXYGENASE; CYCLOPEPTIDE; HS014 CYCLIC PEPTIDE; MELANOCORTIN 4 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DEPRESSION; DRUG MEGADOSE; ELEVATED PLUS MAZE TEST; FORCED SWIM TEST; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LOCUS CERULEUS; LOW DRUG DOSE; MALE; NONHUMAN; NORADRENERGIC SYSTEM; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY; TREATMENT RESPONSE; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; ANXIETY; COMPARATIVE STUDY; DRUG EFFECTS; HYPOPHYSIS ADRENAL SYSTEM; INTRANASAL DRUG ADMINISTRATION; MAZE TEST; PHYSIOLOGICAL STRESS; PREVENTION AND CONTROL; SPRAGUE DAWLEY RAT; STRESS DISORDERS, POST-TRAUMATIC; SWIMMING;

ADMINISTRATION, INTRANASAL; ANIMALS; ANXIETY; DEPRESSION; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MAZE LEARNING; NEUROPEPTIDE Y; PEPTIDES, CYCLIC; PITUITARY-ADRENAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MELANOCORTIN, TYPE 4; STRESS DISORDERS, POST-TRAUMATIC; STRESS, PHYSIOLOGICAL; SWIMMING;

EID: 84952876957     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.12.038     Document Type: Article

References (43)

1. Kearns M.C., Ressler K.J., Zatzick D., Rothbaum B.O. Early interventions for PTSD: a review. Depress Anxiety 2012, 29:833-842.
2. Sones H.M., Thorp S.R., Raskind M. Prevention of posttraumatic stress disorder. Psychiatr Clin N Am 2011, 34:79-94.
3. Cohen H., Matar M.A., Buskila D., Kaplan Z., Zohar J. Early post-stressor intervention with high-dose corticosterone attenuates posttraumatic stress response in an animal model of posttraumatic stress disorder. Biol Psychiatry 2008, 64:708-717.
4. Zohar J., Yahalom H., Kozlovsky N., Cwikel-Hamzany S., Matar M.A., Kaplan Z., et al. High dose hydrocortisone immediately after trauma may alter the trajectory of PTSD: interplay between clinical and animal studies. Eur Neuropsychopharmacol 2011, 21:796-809.
5. Gamber K.M., Macarthur H., Westfall T.C. Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus. Neuropharmacology 2005, 49:646-652.
6. Adamec R., Fougere D., Risbrough V. CRF receptor blockade prevents initiation and consolidation of stress effects on affect in the predator stress model of PTSD. Int J Neuropsychopharmacol 2010, 13:747-757.
7. Kormos V., Gaszner B. Role of neuropeptides in anxiety, stress, and depression: from animals to humans. Neuropeptides 2013, 47:401-419.
8. Caruso V., Lagerstrom M.C., Olszewski P.K., Fredriksson R., Schioth H.B. Synaptic changes induced by melanocortin signalling. Nat Rev Neurosci 2014, 15:98-110.
9. Paschos K.A., Veletza S., Chatzaki E. Neuropeptide and sigma receptors as novel therapeutic targets for the pharmacotherapy of depression. CNS Drugs 2009, 23:755-772.
10. Eaton K., Sallee F.R., Sah R. Relevance of neuropeptide Y (NPY) in psychiatry. Curr Top Med Chem 2007, 7:1645-1659.
11. Sah R., Geracioti T.D. Neuropeptide Y and posttraumatic stress disorder. Mol Psychiatry 2013, 18:646-655.
12. Rasmusson A.M., Schnurr P.P., Zukowska Z., Scioli E., Forman D.E. Adaptation to extreme stress: post-traumatic stress disorder, neuropeptide Y and metabolic syndrome. Exp Biol Med (Maywood) 2010, 235:1150-1162.
13. Pierce M.E., Pritchard L.M. Hypothalamic-pituitary-adrenal axis dysregulation in posttraumatic stress disorder. Psychology of trauma 2013, 225-236. Nova Science Publishers, Inc., Hauppauge, N. Y.
14. O'Donnell T., Hegadoren K.M., Coupland N.C. Noradrenergic mechanisms in the pathophysiology of post-traumatic stress disorder. Neuropsychobiology 2004, 50:273-283.
15. Serova L.I., Tillinger A., Alaluf L.G., Laukova M., Keegan K., Sabban E.L. Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats. Neuroscience 2013, 236:298-312.
16. Serova L.I., Laukova M., Alaluf L.G., Pucillo L., Sabban E.L. Intranasal neuropeptide Y reverses anxiety and depressive-like behavior impaired by single prolonged stress PTSD model. Eur Neuropsychopharmacol 2014, 24:142-147.
17. Serova L.I., Laukova M., Alaluf L.G., Sabban E.L. Intranasal infusion of melanocortin receptor four (MC4R) antagonist to rats ameliorates development of depression and anxiety related symptoms induced by single prolonged stress. Behav Brain Res 2013, 250:139-147.
18. Blasquez C., Jégou S., Friard O., Tonon M.C., Fournier A., Vaudry H. Effect of centrally administered neuropeptide Y on hypothalamic and hypophyseal proopiomelanocortin-derived peptides in the rat. Neuroscience 1995, 68:221-227.
19. Blasquez C., Jégou S., Tranchand Bunel D., Fournier A., Vaudry H. Neuropeptide Y inhibits alpha-MSH release from rat hypothalamic slices through a pertussis toxin-sensitive G protein. Brain Res 1992, 596:163-168.
20. Kokare D.M., Dandekar M.P., Chopde C.T., Subhedar N. Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats. Brain Res 2005, 1043:107-114.
21. Khan S., Liberzon I. Topiramate attenuates exaggerated acoustic startle in an animal model of PTSD. Psychopharmacology (Berl) 2004, 172:225-229.
22. Liberzon I., Sripada C.S. The functional neuroanatomy of PTSD: a critical review. Prog Brain Res 2008, 167:151-169.
23. Yamamoto S., Morinobu S., Takei S., Fuchikami M., Matsuki A., Yamawaki S., et al. Single prolonged stress: toward an animal model of posttraumatic stress disorder. Depress Anxiety 2009, 26:1110-1117.
24. Serova L.I., Laukova M., Alaluf L.G., Sabban E.L. Blockage of melanocortin 4 receptors by intranasal HS014 attenuates single prolonged stress triggered changes in several brain regions. J Neurochem 2014, 131:3920-3933.
25. Pervanidou P., Chrousos G.P. Neuroendocrinology of post-traumatic stress disorder. Prog Brain Res 2010, 182:149-160.
26. Yehuda R. Status of glucocorticoid alterations in post-traumatic stress disorder. Ann N Y Acad Sci 2009, 1179:56-69.
27. Olson V.G., Rockett H.R., Reh R.K., Redila V.A., Tran P.M., Venkov H.A., et al. The role of norepinephrine in differential response to stress in an animal model of posttraumatic stress disorder. Biol Psychiatry 2011, 70:441-448.
28. Drossopoulou G., Antoniou K., Kitraki E., Papathanasiou G., Papalexi E., Dalla C., et al. Sex differences in behavioral, neurochemical and neuroendocrine effects induced by the forced swim test in rats. Neuroscience 2004, 126:849-857.
29. Goyal S.N., Kokare D.M., Chopde C.T., Subhedar N.K. Alpha-melanocyte stimulating hormone antagonizes antidepressant-like effect of neuropeptide Y in Porsolt's test in rats. Pharmacol Biochem Behav 2006, 85:369-377.
30. Page M.E., Detke M.J., Dalvi A., Kirby L.G., Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology (Berl) 1999, 147:162-167.
31. Laukova M., Alaluf L.G., Serova L.I., Arango V., Sabban E.L. Early intervention with intranasal NPY prevents single prolonged stress-triggered impairments in hypothalamus and ventral hippocampus in male rats. Endocrinology 2014, 155:3920-3933.
32. Kash T.L., Winder D.G. Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology 2006, 51:1013-1022.
33. Maniam J., Morris M.J. The link between stress and feeding behaviour. Neuropharmacology 2012, 63:97-110.
34. Serova L.I., Gueorguiev V., Cheng S.Y., Sabban E.L. Adrenocorticotropic hormone elevates gene expression for catecholamine biosynthesis in rat superior cervical ganglia and locus coeruleus by an adrenal independent mechanism. Neuroscience 2008, 153:1380-1389.
35. Johnson L.R., McGuire J., Lazarus R., Palmer A.A. Pavlovian fear memory circuits and phenotype models of PTSD. Neuropharmacology 2012, 62:638-646.
36. Johansen J.P., Cain C.K., Ostroff L.E., LeDoux J.E. Molecular mechanisms of fear learning and memory. Cell 2011, 147:509-524.
37. Finsterwald C., Alberini C.M. Stress and glucocorticoid receptor-dependent mechanisms in long-term memory: from adaptive responses to psychopathologies. Neurobiol Learn Mem 2014, 112:17-29.
38. King P.J., Widdowson P.S., Doods H., Williams G. Regulation of neuropeptide Y release from hypothalamic slices by melanocortin-4 agonists and leptin. Peptides 2000, 21:45-48.
39. Getting S. Targeting melanocortin receptors as potential novel therapeutics. Pharmacol Ther 2006, 111:1-15.
40. Eva C., Serra M., Mele P., Panzica G., Oberto A. Physiology and gene regulation of the brain NPY Y1 receptor. Front Neuroendocrinol 2006, 27:308-339.
41. Hadley M.E., Haskell-Luevano C. The proopiomelanocortin system. Ann N Y Acad Sci 1999, 885:1-21.
42. Herzog H., Hort Y.J., Ball H.J., Hayes G., Shine J., Selbie L.A. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc Natl Acad Sci USA 1992, 89:5794-5798.
43. Ryan K.K., Mul J.D., Clemmensen C., Egan A.E., Begg D.P., Halcomb K., et al. Loss of melanocortin-4 receptor function attenuates HPA responses to psychological stress. Psychoneuroendocrinology. 2014, 42:98-105.